Fluoroscopy Radiation Reduction During Sacral Neuromodulation Lead Placement
Recruiting now · Not applicable
Conditions studied: Radiation Exposure, Overactive Bladder, Urge Incontinence, Urgency-frequency Syndrome
In brief
Fluoroscopy is performed when placing a lead during a sacral neuromodulation procedure. During lead placement, subjects will receive either conventional or experimental fluoroscopic settings. The radiation exposure will be compared between the two groups.
Key facts
- Study ID
- NCT04527445
- Run by
- Loma Linda University
- People needed
- 44
- Starts
- 2026-06-01
- Expected to finish
- 2027-06-01
- Last updated by the study team
- 2026-03-06
Who can join
Age: 18 and older, up to 89. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients undergoing lead implantation for sacral neuromodulation that have overactive bladder as defined by urinary urgency, frequency, nocturia with or without urgency incontinence.
You may not qualify if…
- neurogenic bladder, BMI >40, or peripheral neuropathy.
Where it is running
- Loma Linda University Health — Loma Linda, California, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.